Herpes labialis
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- A lesion caused by type 1 or type 2 herpes simplex virus, typically involving the oralfacial region.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Herpes labialis
- Therapeutic area
- Infectious Disease
- herpes labialis
- cold sore
- cold sores
- herpes labialis
- Herpes simplex, labial
- Sore, cold
- Sores, cold
- blister, fever
- blisters, fever
- fever blister
- fever blisters
- labial Herpes simplex
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Mild
- MONDO ID
- MONDO:0043653
- Parent condition
- MONDO:0004609
Related records
Broader conditions (13)
- Disease
- Disease arising from reactivation of latent virus
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Herpes simplex infectious disease
- Herpesviridae infectious disease
- Human disease
- Infectious disease
- Lip disorder
- Mouth disorder
- Primary viral infectious disease
- Viral infectious disease
Narrower conditions (2)
- Lip herpes simplex type 1 infectious disorder
- Lip herpes simplex type 2 infectious disorder
Trials (52)
- A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers
- A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
- A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis
- A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)
- A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
- A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
- A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
- A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis
- An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
- An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores
- An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
- Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers
- Botulinum Toxin A for Herpes Labialis
- Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.
- Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
- Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
- Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome
- Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
- Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis
- Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Approved drugs (9)
- Acyclovir
- Camphor
- Famciclovir
- Hydrocortisone
- Menthol
- Penciclovir
- Phenol
- Valacyclovir
- Valacyclovir hydrochloride
Drugs in development (12)
- 2-hydroxypropyl-beta-cyclodextrin Phase 2
- Acyclovir sodium Phase 3
- Alcohol Phase 2
- Clobetasol Phase 2
- Glutamine Phase 2
- Glycine Phase 2
- Glycolic acid Phase 2
- Isoxaflutole Phase 2
- NB-001 Phase 3
- Pritelivir Phase 2
- Squaric acid dibutyl ester Phase 2
- ZINC ION Phase 3
Other linked drugs (3)
- Avobenzone
- Onabotulinumtoxina
- Zinc oxide